🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Thymic Epithelial Tumor

An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors NCT07691619Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Postoperative hypo-fractionated radiotherapy Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) Molecular Analysis and Treatment Options of Thymic Malignancies NCT05667948n/a1 site📍 Shanghai Shanghai Chest Hospital · Tests: Chemotherapy Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor NCT06311955Phase 21 site📍 Shanghai Jian Chen · Tests: Carbon ion radiotherapy, combined with platinum-based regimen Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors NCT06301945n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Artificial Intelligence Diagnostics, Recurrence Prediction Tool Establishing Prospective Mediastinal Tumor Database of PUMCH NCT06421805n/a1 site📍 Beijing Peking Union Medical College Hospital Hypofractionated Radiotherapy for Thymic Epithelial Tumors NCT06692062NA1 site📍 Changsha Rongrong Zhou · Tests: Hypofractionated Radiation Therapy Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma NCT07598955Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Cyclophosphamide, Fludarabine, EB-CAR30-NK, EB-CAR5-NK, EB-CARMSLN-NK PT-112 in Subjects With Thymoma and Thymic Carcinoma NCT05104736Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: PT-112 Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors NCT06186726Phase 21 site📍 Shanghai Jian Chen · Tests: carbon ion radiotherapy Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients NCT06523582n/a3 sites📍 Mexico City📍 Mexico City📍 Mexico City Universidad Nacional Autonoma de Mexico Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer NCT04522687n/a1 site📍 Shanghai Shanghai Cancer Hospital, China Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors NCT02146170n/a1 site📍 Bethesda National Cancer Institute (NCI) A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors NCT06248515Phase 24 sites📍 Palo Alto📍 Washington D.C.📍 Chicago Georgetown University · Tests: Sacituzumab govitecan-hziy The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor NCT06311968Phase 21 site📍 Shanghai Jian Chen · Tests: Proton radiotherapy, combined platinum based chemotherapy Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) NCT05558644NA3 sites📍 Paris📍 Paris📍 Suresnes Institut Curie · Tests: single arm for all patients Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma NCT06885697Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: cyclophosphamide, fludarabine, TNhYP218 CAR T Cells, mesothelin expression testing
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy